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SalmonellaUbiquinone, also called coenzyme Q, is a lipid subject to oxido-reduction cycles. It functions in the respiratory
electron transport chain and plays a pivotal role in energy generating processes. In this review, we focus on
the biosynthetic pathway and physiological role of ubiquinone in bacteria. We present the studies which, within
a period of ﬁve decades, led to the identiﬁcation and characterization of the genes named ubi and involved in ubi-
quinone production in Escherichia coli. When available, the structures of the corresponding enzymes are shown
and their biological function is detailed. The phenotypes observed inmutants deﬁcient in ubiquinonebiosynthesis
are presented, either inmodel bacteria or in pathogens. A particular attention is given to the role of ubiquinone in
respiration, modulation of two-component activity and bacterial virulence. This article is part of a Special Issue
entitled: 18th European Bioenergetic Conference.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
In most living organisms, catalytic reactions involved in cell energi-
zation generate electrons which are funneled to the quinone pool.
Thereafter, the reduced quinones (quinols) serve as substrates for
reduction of the terminal acceptors. In Escherichia coli, three kinds of
quinones are involved in this process: ubiquinone, also known as coen-
zyme Q (Q), menaquinone (MK) and demethylmenaquinone (DMK)
[1–3]. MK and DMK have low midpoint potentials (E′° = −74 mV
and +36 mV, respectively, [4]) and are involved in anaerobic respira-
tion while Q, which has a higher midpoint potential (E′° = +100 mV,
[4]), is involved in aerobic respiration [5,6]. The E. coli genome contains
gene clusters for three cytochrome oxidase enzymes: cytochrome bo
oxidase (cyoABCD), cytochrome bd-I oxidase (cydABX) and cytochrome
bd-II oxidase (appCD). The three enzymes function as the major termi-
nal oxidases in the aerobic respiratory chain of E. coli catalyzing electron
transfer from ubiquinol to oxygen [7].Coenzyme Q /Q8; DMK/DMK8,
enzyme Q8; DMQ8, Demethoxy
adenine dinucleotide; FMN,
B, 3-Hydroxybenzoate; 4-HB,
uinone; OHB, 3-Octaprenyl-4-
ol; OPP, 3-Octaprenylphenol;
motive force; O2−, Superoxide
opean Bioenergetic Conference.
actérienne, 31 Chemin Joseph
6 45 79; fax:+334 91 71 89 14.
ights reserved.Ubiquinone is a widespread redox-active lipid which consists of a
conserved aromatic ring and a polyprenyl hydrophobic tail, with the
number of isoprenyl units varying among species: six in Saccharomyces
cerevisiae, eight in E. coli and ten in humans [8–10]. Therefore, E. coli
ubiquinone is designatedQ8. Its biosynthesis is a highly conserved path-
way,which involves a large number of genes, named ubi, that have been
identiﬁed from genetic studies [11,12]. Q8 is located in the bacterial
plasmamembrane andwas described to be an essential element for aer-
obic respiratory growth, gene regulation, oxidative stress adaptation,
and various processes depending upon proton motive force (PMF)
[13–16]. In this review, we present the genes involved in the Q8 biosyn-
thetic pathway in bacteria, with a particular attention on those recently
identiﬁed and on the remaining gaps in current knowledge.We focus on
the enzymatic actors, i.e. those involved in the decoration of the aromat-
ic ring leading to Q8, as well as the accessory ones. A few structures of
Ubi proteins are presented and the phenotypes associated with ubi
mutations are described and discussed.
2. The Q8 biosynthetic pathway in bacteria
The ubi genes have been extensively studied over a period of ﬁve
decades since the pioneering work of Cox and Gibson [17]. Biosynthesis
of Q8 in E. coli requires nine ubi genes, most of them encoding enzymes
that decorate the aromatic ring of the 4-hydroxybenzoate (4-HB) uni-
versal precursor (Fig. 1). Noticeably in E. coli, ubi genes are all scattered
around the chromosome (Fig. 2A and B). It is important to stress that in
a few cases, themutation of genes required for Q8 production led to the
accumulation of 3-octaprenylphenol (OPP), an early intermediate of Q8
biosynthetic pathway (Fig. 1 and Table 1). As a consequence, these
Fig. 1. Biosynthetic pathway of ubiquinone in Escherichia coli. The numbering of the aromatic carbon atoms is shown on coenzyme Q8, and the octaprenyl tail is represented by R on C-3 of
the different biosynthetic intermediates. The name of the enzymes catalyzing the reactions (each labeled with a lowercase letter) is indicated. Abbreviations used for 4-hydroxybenzoate
(4-HB), 3-octaprenyl-4-hydroxybenzoate (OHB), 3-octaprenylphenol (OPP), coenzyme Q8 (Q 8), C1-demethyl-C6-demethoxy-Q 8 (DDMQ8), and C6-demethoxy-Q8 (DMQ8) are
underlined. The XanB2 protein, present in some prokaryotes but not in E. coli, catalyzes the production of 4-HB from chorismate. The biosynthetic intermediates that accumulate in
mutants affected in the different steps are listed in Table 1.
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thetic step altered by the mutation.
In 1968, a screen based on the selection of mutants unable to grow
on malate and examination of the quinone content of these strainsubiBubiJubiE
ubiAubiC
freubiD
ubiF
ubiG
ubiHpepPygfB ubiI
ubiXpurFcvpA
91.62 min
86.58 min
50.39 min
65.81 min
52.34 min
14.97 min
86.74 min
E. coli
100 min.
15
5052
65
87
92 ubiF
ubiGubiX
ubiH-ubiI
ubiE-ubiJ-ubiB
ubiC-ubiA
ubiD
A
B
Fig. 2. Genetic organization and location of ubi genes on the Escherichia coli chromosome.
A. Location of the eleven ubi genes on the 100minmap of the E. coli chromosome. B. Genetic
organization of the ubi genes in E. coli. The location of each gene (or the ﬁrst gene of the
operon) is indicatedon the left. The genes required for ubiquinonebiosynthesis are indicated
in bold. Genes encoding monooxygenases are symbolized by black arrows and genes
encoding methyltransferases are symbolized by gray arrows.grown on glucose led to the identiﬁcation of ubiA as the ﬁrst gene
involved in Q8 biosynthesis [18]. Poole and colleagues found the ubiA
mutant to be unable to grow aerobically on non-fermentable substrates
but able to grow anaerobically on glycerol with alternative electron
acceptors such as fumarate [19]. The ubiA genewas predicted to encode
a membrane-bound 4-hydroxybenzoate octaprenyltransferase. Within
the same operon, ubiA lies downstream the ubiC gene (Fig. 2B). The
UbiC protein catalyzes the ﬁrst committed step in the biosynthesis of
Q8, the conversion of chorismate to 4-HB (Reaction a, Fig. 1) [20]. Inter-
estingly, in Xanthomonas campestris (which does not contain any ubiC
gene or homologue), the XanB2 protein was reported to convert
chorismate into 3-HB or 4-HB using two distinct catalytic domains not
related to UbiC (Reaction a, Fig. 1) [21].
Mutation in the E. coli ubiG gene yields strains unable to grow aero-
bically on nonfermentable substrates [22]. UbiG is one of the few Ubi
enzymes that has been puriﬁed and assayed in vitro. Activity assays
showed that UbiG is a S-adenosylmethionine (SAM)-dependent meth-
yltransferase, which catalyzes the two O-methylation steps of Q8
biosynthesis (Reactions e and i, Fig. 1) [23].
The ubiE gene encodes the second, also SAM-dependent, meth-
yltransferase of the Q 8 biosynthetic pathway (Reaction g, Fig. 1)
[24]. The ubiE mutant is deﬁcient for growth on succinate and
accumulates demethyldemethoxy-coenzyme Q 8 (DDMQ8) and
demethylmenaquinone (DMK8) as predominant intermediates
(Table 1), leading to the conclusion that ubiE is required for C-
methylation in both ubiquinone and menaquinone synthesis [24].
An E. coli ubiDmutant accumulates 3-octaprenyl-4-hydroxybenzoate
(OHB) (Reaction c, Fig. 1) [25,26]. It was shown that a partially puriﬁed
membrane-bound UbiD protein was able to convert OHB into OPP,
strongly suggesting UbiD involvement in the decarboxylation step of Q8
biosynthesis [26]. However, a ubiDmutant retains the ability to produce
about 25% of the wild-type levels of Q8, consistent with the existence of
a second decarboxylase [26]. Inactivation of the ubiX gene leads to low
levels of Q8, a reduced growth on succinate and accumulation of OHB
(Table 1), suggesting a decarboxylase activity for UbiX [27]. A hypothesis
is that UbiD and UbiX, which share no sequence similarity, function
together during the decarboxylation of OHB (Reaction c, Fig. 1) [27].
Moreover, it might be worth noting that in Salmonella enterica serovar
Paratyphi, ubiX and ubiD are organized as a single fusion gene
ubiX-ubiD (SPA2778 gene). In E. coli O157:H7, in addition to UbiD and
UbiX, a probable aromatic acid decarboxylase called Pad1was identiﬁed
but its role in Q8 biosynthesis has not been investigated so far.
Hydroxylations represent three of the nine reactions required for Q8
biosynthesis in E. coli. These reactions introduce hydroxyl groups at
positions C-5, C-1, and C-6 of the aromatic ring of Q8 (Reactions d, f
and h, Fig. 1), and the genes encoding these enzymes were proposed
to be ubiB, ubiH, and ubiF, respectively (Fig. 2A and B) [28]. ubiH was
the ﬁrst of these genes to be identiﬁed and, based on sequence compar-
ison, was proposed to be a ﬂavin-containing monooxygenase [29].
A ubiF mutant was shown to accumulate demethoxy coenzyme Q8
Table 1
Accumulated intermediates from the Q8 biosynthetic pathway in Escherichia colimutants.
Gene affected
by the mutationa
Deﬁcient
reaction
Accumulated
Q8-intermediatesb
Reference
ubiB Not known OPP [31]
ubiC a Nonec [73]
ubiD c OHBc [27]
ubiX c OHBc [27]
ubiI d 4-HP8c [32]
ubiG e and i OPP and compound 3 (Fig. 1) [74]
ubiE g DDMQ8 [24]
ubiF h DMQ8 [30]
ubiA b No prenylated products formed [19]
ubiJ Not known No intermediate characterized [34]
ubiH f OPP, compounds 1 and 2 (Fig. 1) [75]
a Themutations that affect the ubi genes reported in this table vary frompointmutation
to transposon insertion or complete deletion. See references for details.
b As detected by the techniques used in the reported studies. For example, OPP is ade-
quately detected by using radiolabeled 4-HB but is not evidenced when using electro-
chemical detection coupled to HPLC.
c A low level of Q8 is observed in these strains.
Fig. 3. Structure of the chorismate lyase UbiC from Escherichia coli. Crystal structure of the
chorismate lyaseUbiC from E. coli in complexwith the4-hydroxybenzoate, 1.0Å resolution
(PDB ID: 1TT8) [37]. The core of the protein fold is a 6-stranded antiparallel β-sheet, with
two helix–turn–helix loops colored in yellow and orange. The two internal cavities are
colored in gray. The 4-HB product is located in one of these cavities, behind the two ﬂaps
in a hydrophobic pocket.
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containing monooxygenases, was responsible for introducing a hydroxyl
group at C-6 of the aromatic ring [30]. UbiB was initially proposed to
be involved in the C-5 hydroxylation because a ubiBmutant was shown
to accumulate OPP and failed to produce Q8 (Table 1) [25,31]. However,
the UbiB protein does not contain any signature sequence for
monooxygenases but rather shares identity with a large family of
eukaryotic-type protein kinases [31]. Actually, we discovered that the
C-5 hydroxylase was the product of the visC gene [32]. Accordingly,
the visC gene, locating immediately downstream of ubiH within the
same operon, was renamed ubiI (Fig. 2B). A ubiImutant has a low level
of Q8 and accumulates 3-octaprenyl-4-hydroxyphenol (4-HP8), an in-
termediate that results from a C5-hydroxylation defect (Table 1) [32].
In fact, 4-HP8 is formed by hydroxylation of OPP on C1 by UbiH without
reaction d and e taking place (Fig. 1). Therefore, the UbiH protein is able
to perform the C1-hydroxylation in the absence of the methoxyl group
on C5. The UbiI protein displays the typical domains of ﬂavin-
containing monooxygenases and shares 30 and 39% sequence identity
with UbiH and UbiF, respectively [32]. Thus, we proposed to assign to
UbiI the ﬁrst hydroxylation step in Q8 biosynthesis (Reaction d, Fig. 1)
[32]. The role of the ubiB gene product remains to be investigated.
In E. coli, the yigP gene (called ubiJ in Fig. 2B) lies in between the ubiE
and ubiB genes [31]. Recently, yigPwas proposed to encode a small RNA
of 252 nucleotides (referred to as esrE), which was proposed to be
essential in E. coli [33]. We also characterized the yigP gene in E. coli
and Salmonella and our results did not support these conclusions as
yigP deletions were obtained in both bacteria. We found yigP to be
required for Q8 biosynthesis and we changed the name of yigP into
ubiJ [34]. Regarding the small RNA issue, a “scrambled” ubiJ allele
including the mutation of 30% of the nucleotides without changing the
amino acid sequence restored Q8 biosynthesis in Salmonella ubiJmutant
[34].We therefore believe that the biological function of ubiJ ismediated
by a protein.We also demonstrated that a ubiJmutant was impaired for
growth under aerobic conditions, but did not present any growth defect
anaerobically, either with glucose or glycerol supplementedwith differ-
ent electron acceptors [34].
In conclusion, all enzymatic reactions necessary for Q8 biosynthesis in
aerobic conditions have been assigned to a Ubi protein (Fig. 1). However,
the role of UbiB and UbiJ proteins remains to be established, as they are
also essential for this process.
3. Structural analysis
The E. coli chorismate lyase UbiC structure was solved at 1.4 Å reso-
lution [35,36]. This monomeric enzyme is composed of 164 amino acidresidues with a molecular weight of 19 kDa [19]. The fold involves a
6-stranded antiparallel β-sheet with no spanning helices and novel
connectivity [36]. Moreover, the 4-HB is completely sequestered
from solvent in a largely hydrophobic environment behind two
helix–turn–helix loops [36]. Ultrahigh resolution (1.0 Å) crystal structure
of the E. coli UbiC product complex (PDB ID: 1TT8) reveals details of a
substrate-sized internal cavity, also behind the ﬂaps, near the product
site (Fig. 3) [37]. A common feature of the UbiC structures is the presence
of two internal-binding pockets connected by a short tunnel [37].
Structural information about the UbiX decarboxylase are available
from studies carried out in Pseudomonas aeruginosa and E. coli O157:
H7. The P. aeruginosaUbiX structure was determined to 1.5 Å resolution
[38]. It shows that the enzyme assembles into a dodecamer, each
subunit displaying a typical Rossmann fold, and contains one Flavin
MonoNucleotide (FMN) at the interface between two subunits (PDB
ID: 3ZQU) [38]. A paralog of UbiX named Pad1 (52% identity) was iden-
tiﬁed in E. coliO157:H7. Its three-dimensional structure has been deter-
mined and reﬁned at 2.0 Å resolution (PDB ID: 1SBZ) (Fig. 4A) [39]. Each
Pad1 monomer of the dodecameric assembly consists of a typical
Rossmann fold and contains a non-covalently bound molecule of FMN
(Fig. 4A) [39]. The FMN cofactor also lies at the interface between two
monomers. As expected, the structures of UbiX from P. aeruginosa and
Pad1 from E. coli O157:H7 are highly comparable as shown by the
root-mean-square deviation of aligned Cα atoms in the range 1.1–1.5
Å (Fig. 4B).
Structural information for the UbiD decarboxylase derived from
studies carried out in P. aeruginosa and E. coli. Two genes, PA0254 and
PA5237, predicted to encode UbiD homologs arise in P. aeruginosa
[40]. The three-dimensional structure of PA0254 has been determined
in two different crystal forms to resolutions of 1.95 and 2.3 Å, respec-
tively, showing a dimeric assembly (PDB ID: 4IP2) (Fig. 5A). Strikingly,
the quaternary structure of P. aeruginosa PA0254 (25% identity with
E. coli UbiD) differs from the hexameric organization of UbiD from
E. coli (PDB ID: 2IDB, unpublished, Fig. 5B) and of PA5237 (76% identity
with E. coli UbiD) [40]. Each subunit of PA0254, whose overall fold is
Fig. 4. Structures of the UbiX decarboxylase from Pseudomonas aeruginosa and the Pad1 paralog from Escherichia coli O157:H7. A. Crystal structure of the dodecameric Pad1 from E. coli
O157:H7 complexed with a ﬂavin mononucleotide (FMN), 2.0 Å resolution (PDB ID: 1SBZ) [39]. The view along the threefold axis shows the trimeric arrangement of Pad1. Each subunit
is shown in a different color. The FMN cofactor is shown as yellow sticks and its binding site is located at the interface between two monomers. B. Superimposition of one subunit of the
dodecameric Pad1 from E. coliO157:H7 (in green)with the corresponding subunit of the dodecamericUbiX from Pseudomonas aeruginosa (PDB ID3ZQU) (in red). Theﬂavin cofactors FMN
of the two proteins are colored in green in UbiX and in red in Pad1.
Fig. 5. Structures of the UbiD decarboxylases from Pseudomonas aeruginosa and Escherichia
coli. A. Crystal structure of thedimeric PA0254 from P.aeruginosa, a putative aromatic acid de-
carboxylase bearing aC-terminal domain characteristic of theUbiDprotein family, 1.95Å res-
olution (PDB ID: 4IP2) [40]. The threedomains of each subunit are shown in blue (N-terminal
domain), green (middle domain) and red (C-terminal domain). The magnesium site is indi-
catedby ablack sphere in themiddle domain. B. Crystal structure of thehexamericUbiD from
E. coli (PDB ID: 2IDB). Each subunit is shown in a different color.
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N-terminal part of the molecule is built up of two domains that pack
tightly to eachother and aC-terminalα/βdomainwhichdisplays a topol-
ogy characteristic for the UbiD protein family [40]. The middle domain
shows signiﬁcant structural similarity to the FMN-binding split barrel
from a family of ﬂavoproteins, including the NADH: FMN oxidoreductase
fromMethylobacillus ﬂagelates (PDB ID: 3E4V), the ﬂavin reductase from
Shewanella baltica (PDB ID: 3HMZ), or theﬂavoredoxin fromDesulfovibrio
vulgaris (PDB ID: 2D5M). This middle domain also contains ametal bind-
ing site, with a magnesium ion coordinated by two histidine and gluta-
mate residues, which are conserved in the corresponding metal binding
site of some FMN binding proteins. However, no evidence for the incor-
poration of a ﬂavin cofactor in PA0254 is available so far.
Recently, we determined the crystal structure of a truncated form of
UbiI, involved in the aerobic C5-hydroxylation reaction (Fig. 6A) [32].
Only this form, lacking the 35C-terminal residues, and not the full-
length protein, too prone to precipitate, could crystallize. Nevertheless,
this structure provides some useful information, in particular as it
shares many features with that of the canonical FAD-containing para-
hydroxybenzoate hydroxylase (PHBH) [41]. In particular, comparison
with PHBH reveals a FAD binding site in UbiI (Fig. 6B) which has been
validated by site directed mutagenesis, thus supporting that UbiI and
probably UbiH and UbiF are indeed FAD-containing monooxygenases
[32].
As shown from this brief survey, it is obvious that a lot is still missing
regarding the structural biology of Q8 pathway: few proteins have been
structurally characterized and rather incomplete information has been
gained from those which have been crystallized. This opens a large
ﬁeld of research for the future.
4. Physiological role of Q8
4.1. Interplay between Q8 and redox sensing two-component systems
The Arc (anoxic redox control) two-component system of E. coli
comprises the ArcB transmembrane sensor kinase and the cytosolic
ArcA response regulator. It plays a major role in a transcriptional
regulatory network that allows facultative anaerobic bacteria to sense
various respiratory growth conditions [42]. Georgellis and colleagues
showed that quinones act as direct negative signals that inhibit
Fig. 6. Structure of the UbiI monooxygenase from Escherichia coli. A. Crystal structure of the C-terminal truncated form of E. Coli C5-hydroxylase UbiI involved in Q8 biosynthesis, 2.0
Å resolution (PDB ID: 4 K22) [32]. B. Proposed molecular docking model of UbiI with FAD. The ﬂavin cofactor is shown as yellow sticks.
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that the oxidative power provided by the Q8 pool induced the formation
of two intermolecular cysteine disulﬁde bonds within the cytosolic do-
mains of an ArcB dimer, leading to the inactivation of ArcB kinase activity
[43,44]. Bekker and colleagues provided evidence that additional regula-
tion of ArcB kinase activity by the redox state of menaquinone (MK8)
was prevalent undermicroaerobic to anaerobic conditions [45]. They con-
cluded that activation of the ArcBA system was controlled by both MK8
and Q8 pools [45]. Moreover, the extent of ArcA phosphorylation was
shown to be modulated by the oxygen supply rate in an ubiE mutant,
leading to the conclusion that the oxidized form of DMK8 could inactivate
ArcB [46]. However, the authors did not take in consideration the DDMQ8
which also accumulates in a ubiEmutant [24,34] and could play a role in
ArcB regulation in the ubiEmutant. A complementary study demonstrat-
ed that (D)MK8 was required for activation of ArcB upon a shift to anoxic
conditions [4]. The midpoint redox potential of the cysteines of ArcB was
determined to be approximately−41 mV, which is in agreement with
the proposed model in which the Q8 pool can oxidize these cysteines
under aerobic conditions and the disulﬁde bonds can be reduced by the
(D)MK8 pool upon a shift to anaerobic conditions [4].
Another example of redox regulation is illustrated by the RegBA
two-component system of Rhodobacter capsulatus. RegB is a membrane-
spanning sensor kinase that autophosphorylates and transfers the phos-
phoryl group to its cognate response regulator RegA [47]. The RegB/
RegA system regulates the synthesis of numerous energy-generating
and energy-utilizing systems [48]. Recently, RegB was shown to bind
weakly both oxidized and reducedQ8with nearly equal afﬁnity, although
oxidized Q8 alone inhibited kinase activity [49]. The current view is that
interaction of RegB with both the reduced and oxidized forms of Q8
allows the kinase to monitor and tune the cellular energy state [49].
In conclusion, in both E. coli and R. capsulatusmodels, and presum-
ably many other bacteria, a connection between the pool, and the
redox state, of Q8 and two-component systems endows the cell with
the capacity to modulate the expression of multiple genes in response
to changes in redox conditions.
4.2. Q8 and oxidative stress
The involvement of ubiquinone in oxidative stress resistance was
ﬁrst addressed in eukaryotes, where it was suggested that its reducedform, i.e. ubiquinol, was able to function as a lipid-soluble anti-oxidant
[50]. Ubiquinol was shown to scavenge lipid peroxyl radicals and there-
by prevents a chain reaction causing oxidative damage to polyunsatu-
rated fatty acids of biological membranes, a process known as lipid
peroxidation [51]. In yeast, the biosynthetic intermediate DMQ6 was
concluded to lack antioxidant activity because it failed to protect cells
against oxidative stress generated by hydrogen peroxide (H2O2) or
linolenic acid [52]. In prokaryotes, an exhaustive study aimed at investi-
gating the role of Q8 in resistance against oxidative stress was carried
out by Søballe and Poole [53]. Using a ubiCA mutant deﬁcient for Q8
production, they observed an accumulation of superoxide (O2•−) in
the membranes of the mutant compared to wild-type membranes,
reﬂecting the lack of superoxide-scavenging ubiquinol [53]. Moreover,
intracellular H2O2 concentration was increased 1.8-fold in the ubiCA
mutant, which was also found to be hypersensitive to an oxidative
stress mediated by H2O2 [53]. Expression of katG gene, encoding a cata-
lase, and intracellular catalase activity, were both increased in the ubiCA
mutant [53]. These observations are consistent with the hypothesis that
Q8 limits O2•− and H2O2 accumulation in scavenging reactive oxygen
species. However, given the multiplicity of catalases, peroxidases and
superoxide dismutases present in most bacteria, the relative contribu-
tion of Q8 to the overall anti-oxidative stress defenses system remains
to be assessed.
4.3. Q8 and respiration
The respiratory chain of E. coli contains many enzymes allowing the
organism to transfer electrons to oxygen or to use alternative terminal
acceptors such as nitrate, dimethyl sulfoxide (DMSO), trimethylamine
N-oxide (TMAO) or fumarate [1,2,7]. Q8 is generally depicted as the
aerobic quinone since it is more abundant than MK8 during aerobic
growth, whereas MK8 is essential for anaerobic respiration using fuma-
rate, DMSO and TMAO as electron acceptors [13,14]. In this way, a ubiCA
mutant showed severely diminished growth yields aerobically but not
anaerobically using nitrate or fumarate as terminal electron acceptors
[54]. Conversely, a ubiE mutant, which contains DMK8 but no MK8,
was able to growwith fumarate, TMAO and DMSO, but not with nitrate
as electron acceptor [55]. It was then concluded that DMK8 (in addition
to MK8) could serve as a redox mediator in fumarate, TMAO and DMSO
respiration, but not in nitrate respiration [55]. Moreover, it was
1009L. Aussel et al. / Biochimica et Biophysica Acta 1837 (2014) 1004–1011demonstrated that nitrate reductase A could accept electrons from both
Q8 and MK8 pools, the coupling being more effective with ubiquinol
than with menaquinol [56].
Recently, Bekker and colleagues reported that DMK8 played a role
not only in TMAO−, DMSO- and fumarate-dependent respiration, but
also in oxidation of succinate [15]. They further concluded that all
three quinol oxidases of E. coli accepted electrons from DMK8 based
on the residual aerobic respiration observed in a ubiE mutant [15]. As
already mentioned, another hypothesis is that DDMQ8 might provide
electron towards the quinol oxidases in the ubiEmutant. In the future,
it will be interesting to know whether these remaining uncertainties
will challenge the classic view associating ubiquinone to aerobic growth
and menaquinone to anaerobic growth.
4.4. Q8 and antibiotics resistance
The proton-pumping NADH:ubiquinone oxidoreductase, also called
complex I, catalyzes the electron transfer from NADH to Q8 linked
with a proton translocation from the negative inner to the positive
outer side of the membrane [57]. Thus, a proton-motive (PMF) force is
generated,which is utilizedmainly for ATP synthesis. PMF is instrumen-
tal in allowing either import or export of antibiotics [58–60]. As a conse-
quence, ubi mutations are likely to modify levels of resistance to
antibiotics sustained by bacteria. In fact, resistance to low levels of
aminoglycoside antibiotics has been used for long for the isolation of
menaquinone-deﬁcient mutants in Bacillus subtilis since the MK
deﬁciency depresses the rate of accumulation of aminoglycosides,
which accounts for the resistance phenotype [61]. Thereby, a phenotype
of increased aminoglycoside resistance led to the identiﬁcation of the
aarE gene, the ubiA homologue in Providencia stuartii [62]. In E. coli, a
ubiF mutation was associated with pleomycin resistance [63] while a
ubiDmutation was found to be associated with decreased transport of
streptomycin and gentamicin, and increased resistance to those antibi-
otics [64]. This mutant also exhibited increased resistance to several
other aminoglycoside antibiotics, but not spectinomycin [64]. A series
of E. colimutants located in the vicinity of ubiB and ubiD and consistent
with a disruption of Q8 synthesis were found to present zwittermicin A
resistance, a novel broad-spectrum antibiotics produced by Bacillus
cereus [65]. Rationally, a ubiDmutant was also resistant to zwittermicin
A [65]. All together, these studies highlight that connections between
Q8 production and antibiotics resistance occur in many bacteria.
4.5. Q8 and bacterial virulence
In the Caenorhabditis elegansmodel, Clarke and colleagues revealed
that nematodes fed diets of respiratory deﬁcient E. coli lacking Q8
lived signiﬁcantly longer than worms fed the wild-type parental strain
[66]. Moreover, these E. colimutants were degraded in the early adult
worm and did not accumulate in the intestinal tract [66]. These data
led the authors to propose that bacterial respiration might act as a viru-
lence factor, inﬂuencing the ability of bacteria to colonize – and subse-
quently harm – the animal host [66]. As a matter of fact, the role of
respiration in host–pathogen interactions has recently been underlined
in several studies, including those dedicated to Shigella pathogenicity
[67] and more recently to Salmonella [34].
Indeed, early studies brought in light the requirement of a functional
Q8 biosynthesis pathway for the ﬂagellation of Salmonella [68]. Interest-
ingly, the increase in motility response occurred within a narrow range
of the increase in Q8 content [68]. More recently, we showed that
Salmonella ubiJ mutant, a strain deﬁcient for Q 8 production under
aerobic conditions, was killed within macrophages [34]. When macro-
phages were infected with an anaerobic inoculum of the ubiJmutant (in
which Q8 was still produced), the ubiJmutant recovered its proliferation
capacity, clearly establishing the requirement for Q8 for efﬁcient intracel-
lular proliferation [34]. Several possibilities can be considered to connect
Q8 defects and virulence attenuation: (i) the necessity for the bacteriumto use aerobic respiration – thus Q8 – to grow intracellularly; (ii) the
antioxidant role of Q8 to avoid the oxidative burst produced by the
host; (iii) the requirement of a PMF-dependent process for virulence.
Thereby, our recent data combined to results from other groups
highlighted the importance of Q8 biosynthesis in the context of the
host–pathogen interplay and revealed an unexpected link between Q8
and bacterial virulence.
5. Conclusion and perspectives
In this review, we have presented the actors involved in Q8 biosyn-
thetic pathway. Phenotypic characterizations of variousmutants coupled
with the examination of Q8 content led to the identiﬁcation of genes
involved in the decoration of the aromatic ring, from the 4-HB precursor
to theﬁnal ubiquinone.When available, the three-dimensional structures
of these enzymes were presented. Last, the role of Q8 in diverse cellular
processes was detailed: genetic regulation through the two-component
systems ArcBA and RegBA, adaptation to oxidative stress, respiration,
antibiotics resistance and bacterial virulence.
Whereas nine ubi genes were found to be directly involved in Q8
biosynthesis, the biological function of ubiB and ubiJ gene products
remain unknown. The involvement of UbiB in the C-5 hydroxylation
step has to be deﬁnitively abandoned. Instead, UbiB might play a regu-
latory role through a kinase activity, even though it is still unknown if
it displays such an activity and what substrate it acts on. Based on
sequence similarities between ubiJ and genes involved in lipid metabo-
lism, UbiJ could serve as a carrier of the isoprenoid hydrophobic tail
prior the action ofmonooxygenases andmethyltransferases. Alternative-
ly, it might chaperone prenylated intermediates during the biosynthetic
process.
Intriguingly, we found that the ubiJ mutant synthesizes almost
wild-type levels of Q8 under anaerobic growth conditions [34]. Actually,
ubiH, ubiF and ubiI mutants also synthesize signiﬁcant levels of Q8
anaerobically [28,32]. The three latter genes encode ﬂavin-dependent
monooxygenases, which usemolecular oxygen to catalyze their respec-
tive hydroxylation reactions. In consequence, these proteins will not
participate in Q8 biosynthesis under anaerobic conditions because of
the absence of molecular oxygen. Therefore, alternative anaerobic
hydroxylases must carry out the hydroxylation reactions in anaerobic
conditions as proposed by Alexander and Young [28], but so far the
identity of these proteins has remained elusive. The involvement of
UbiJ only in aerobic Q8 biosynthesis is more difﬁcult to rationalize
than that of the aerobic monooxygenases and may reﬂect a functional
link with those enzymes.
It is important to note that with the exception of the E. colimethyl
transferase UbiG [23], the partially puriﬁed membrane-bound UbiD
[26] and theUbiA octaprenyltransferase [69], noneof the other enzymes
(the decarboxylases, the putative kinase and the hydroxylases) that
participate to Q8 biosynthesis have been assayed under in vitro condi-
tions using pure proteins. As a consequence,most of the predicted activ-
ities associated with Ubi enzymes remain to be fully established by
straight biochemical analyses. This is not surprising considering the
difﬁculties to purify these proteins, their probable association to the
membranes and their instability, as well as the difﬁculties to get access
to the substrates, not commercially available.
Another issue is whether Ubi proteins may belong to a large multi-
protein complex as suggested by an early report [70]. By a combination
of sonication, gel ﬁltration and equilibrium sedimentation with a sucrose
gradient, the author puriﬁed amega complex of at least 12 proteins, rang-
ing from 40 to 80 kDa and exhibiting a molecular weight estimated to
2.106 Da. This complex had the capacity to process OPP into Q8 in the
presence of NADPH, SAM and O2. It is intriguing that, in spite of this
fascinating observation, no further studies concerning this bacterial com-
plex have been reported then. The existence of a high-molecular weight
complex has also been documented in Saccharomyces cerevisiae, mostly
by genetic and partly by biochemical studies [71,72]. The complex may
1010 L. Aussel et al. / Biochimica et Biophysica Acta 1837 (2014) 1004–1011actually consist of several subcomplexes likely associated with the mito-
chondrial innermembrane [72], but neither its complete composition nor
its structural organization is known. In particular, the puriﬁcation of this
complex has not been reported. Thus, the question of the existence of a
Q8 biosynthetic complex in bacteria remains open and needs further
investigation.Acknowledgements
Thanks are due to the members of the FB group for fruitful discus-
sions. We acknowledge Ludovic Pecqueur for the help in the prepara-
tion of molecular graphics ﬁgures with PyMol. This work was funded
by the CNRS, Aix-Marseille Université (AMU), the Institut Universitaire
de France (IUF), and the French State Program “Investissements
d'Avenir” (Grant “LABEX DYNAMO”, ANR-11-LABX-0011).References
[1] G. Unden, J. Bongaerts, Alternative respiratory pathways of Escherichia coli: energetics
and transcriptional regulation in response to electron acceptors, Biochim. Biophys.
Acta 1320 (1997) 217–234.
[2] R.K. Poole, G.M. Cook, Redundancy of aerobic respiratory chains in bacteria? Routes,
reasons and regulation, Adv. Microb. Physiol. 43 (2000) 165–224.
[3] I. Belevich, V.B. Borisov, M.I. Verkhovsky, Discovery of the true peroxy intermediate
in the catalytic cycle of terminal oxidases by real-time measurement, J. Biol. Chem.
282 (2007) 28514–28519.
[4] A.F. Alvarez, C. Rodriguez, D. Georgellis, Ubiquinone and menaquinone electron
carriers represent the yin and yang in the redox regulation of the ArcB sensor
kinase, J. Bacteriol. 195 (2013) 3054–3061.
[5] B. Schoepp-Cothenet, C. Lieutaud, F. Baymann, A. Vermeglio, T. Friedrich, D.M.
Kramer, W. Nitschke, Menaquinone as pool quinone in a purple bacterium, Proc.
Nat. Acad. Sci. U. S. A. 106 (2009) 8549–8554.
[6] A. Nakamura, T. Suzawa, Y. Kato, T. Watanabe, Species dependence of the redox
potential of the primary electron donor p700 in photosystem I of oxygenic photo-
synthetic organisms revealed by spectroelectrochemistry, Plant Cell Physiol. 52
(2011) 815–823.
[7] V.B. Borisov, R.B. Gennis, J. Hemp, M.I. Verkhovsky, The cytochrome bd respiratory
oxygen reductases, Biochim. Biophys. Acta 1807 (2011) 1398–1413.
[8] B. Nowicka, J. Kruk, Occurrence, biosynthesis and function of isoprenoid quinones,
Biochim. Biophys. Acta 1797 (2010) 1587–1605.
[9] M. Bentinger, M. Tekle, G. Dallner, Coenzyme Q-biosynthesis and functions,
Biochem. Biophys. Res. Commun. 396 (2010) 74–79.
[10] M. Turunen, J. Olsson, G. Dallner, Metabolism and function of coenzyme Q, Biochim.
Biophys. Acta 1660 (2004) 171–199.
[11] R. Meganathan, Ubiquinone biosynthesis in microorganisms, FEMS Microbiol. Lett.
203 (2001) 131–139.
[12] U.C. Tran, C.F. Clarke, Endogenous synthesis of coenzyme Q in eukaryotes,
Mitochondrion 7 (2007) S62–S71.
[13] B.J. Wallace, I.G. Young, Role of quinones in electron transport to oxygen and nitrate
in Escherichia coli. Studies with a ubiA- menA- double quinone mutant, Biochim.
Biophys. Acta 461 (1977) 84–100.
[14] B. Søballe, R.K. Poole, Microbial ubiquinones: multiple roles in respiration, gene
regulation and oxidative stress management, Microbiology 145 (1999) 1817–1830.
[15] P. Sharma, M.J. Teixeira deMattos, K.J. Hellingwerf, M. Bekker, On the function of the
various quinone species in Escherichia coli, FEBS J. 279 (2012) 3364–3373.
[16] S. Grimaldi, B. Schoepp-Cothenet, P. Ceccaldi, B. Guigliarelli, A. Magalon, The
prokaryotic Mo/W-bisPGD enzymes family: a catalytic workhorse in bioenergetic,
Biochim. Biophys. Acta 1827 (2013) 1048–1085.
[17] G.B. Cox, F. Gibson, Biosynthesis of vitamin K and ubiquinone. Relation to the
shikimic acid pathway in Escherichia coli, Biochim. Biophys. Acta 93 (1964)
204–206.
[18] G.B. Cox, F. Gibson, J. Pittard, Mutant strains of Escherichia coli K-12 unable to form
ubiquinone, J. Bacteriol. 95 (1968) 1591–1598.
[19] G. Wu, H.D. Williams, F. Gibson, R.K. Poole, Mutants of Escherichia coli affected in
respiration: the cloning and nucleotide sequence of ubiA, encoding the membrane-
bound p-hydroxybenzoate:octaprenyltransferase, J. Gen. Microbiol. 139 (1993)
1795–1805.
[20] B.P. Nichols, J.M. Green, Cloning and sequencing of Escherichia coliubiC andpuriﬁcation
of chorismate lyase, J. Bacteriol. 174 (1992) 5309–5316.
[21] L. Zhou, J.Y. Wang, J.H. Wang, A. Poplawsky, S.J. Lin, B.S. Zhu, C.Q. Chang, T.L. Zhou,
L.H. Zhang, Y.W. He, Mol. Microbiol. 87 (2013) 80–93.
[22] G.Wu, H.D.Williams, M. Zamanian, F. Gibson, R.K. Poole, Isolation and characterization
of Escherichia colimutants affected in aerobic respiration: the cloning and nucleotide
sequence of ubiG. Identiﬁcation of an S-adenosylmethionine-binding motif in protein,
RNA, and small-moleculemethyltransferases, J. Gen.Microbiol. 138 (1992) 2101–2112.
[23] W.W. Poon, R.J. Barkovich, A.Y. Hsu, A. Frankel, P.T. Lee, J.N. Shepherd, D.C. Myles,
C.F. Clarke, Yeast and rat Coq3 and Escherichia coli UbiG polypeptides catalyze
both O-methyltransferase steps in coenzyme Q biosynthesis, J. Biol. Chem. 274
(1999) 21665–21672.[24] P.T. Lee, A.Y. Hsu, H.T. Ha, C.F. Clarke, A C-methyltransferase involved in both
ubiquinone and menaquinone biosynthesis: isolation and identiﬁcation of the
Escherichia coli ubiE gene, J. Bacteriol. 179 (1997) 1748–1754.
[25] G.B. Cox, I.G. Young, L.M. McCann, F. Gibson, Biosynthesis of ubiquinone in
Escherichia coli K-12: location of genes affecting the metabolism of 3-octaprenyl-
4-hydroxybenzoic acid and 2-octaprenylphenol, J. Bacteriol. 99 (1969) 450–458.
[26] R.A. Leppik, I.G. Young, F. Gibson, Membrane-associated reactions in ubiquinone
biosynthesis in Escherichia coli. 3-Octaprenyl-4-hydroxybenzoate carboxy-lyase,
Biochim. Biophys. Acta 436 (1976) 800–810.
[27] M. Gulmezian, K.R. Hyman, B.N. Marbois, C.F. Clarke, G.T. Javor, The role of UbiX in
Escherichia coli coenzyme Q biosynthesis, Arch. Biochem. Biophys. 467 (2007)
144–153.
[28] K. Alexander, I.G. Young, Alternative hydroxylases for the aerobic and anaerobic
biosynthesis of ubiquinone in Escherichia coli, Biochemistry 17 (1978) 4750–4755.
[29] K. Nakahigashi, K. Miyamoto, K. Nishimura, H. Inokuchi, Isolation and characterization
of a light-sensitive mutant of Escherichia coli K-12 with a mutation in a gene that is
required for the biosynthesis of ubiquinone, J. Bacteriol. 174 (1992) 7352–7359.
[30] O. Kwon, A. Kotsakis, R. Meganathan, Ubiquinone (coenzyme Q) biosynthesis in
Escherichia coli: identiﬁcation of the ubiF gene, FEMS Microbiol. Lett. 186 (2000)
157–161.
[31] W.W. Poon, D.E. Davis, H.T. Ha, T. Jonassen, P.N. Rather, C.F. Clarke, Identiﬁcation of
Escherichia coli ubiB, a gene required for the ﬁrst monooxygenase step in ubiquinone
biosynthesis, J. Bacteriol. 182 (2000) 5139–5146.
[32] M. Hajj Chehade, L. Loiseau, M. Lombard, L. Pecqueur, A. Ismail, M. Smadja, B.
Golinelli-Pimpaneau, C. Mellot-Draznieks, O. Hamelin, L. Aussel, S. Kieffer-Jaquinod,
N. Labessan, F. Barras, M. Fontecave, F. Pierrel, A new gene involved in coenzyme Q
biosynthesis in Escherichia coli: UbiI functions in aerobic C5-hydroxylation, J. Biol.
Chem. 288 (2013) 20085–20092.
[33] Z. Chen, Y. Wang, Y. Li, Y. Li, N. Fu, J. Ye, H. Zhang, Esre: a novel essential non-coding
RNA in Escherichia coli, FEBS Lett. 586 (2012) 1195–1200.
[34] L. Aussel, L. Loiseau, M. Hajj Chehade, B. Pocachard, M. Fontecave, F. Pierrel, F. Barras,
Coenzyme Q biosynthesis in Escherichia coli and Salmonella typhimurium: ubiJ, a
new gene required for aerobic growth and proliferation in macrophage, J. Bacteriol.
196 (2014) 70–79.
[35] C. Stover, M.P. Mayhew, M.J. Holden, A. Howard, D.T. Gallagher, Crystallization and
1.1-A diffraction of chorismate lyase from Escherichia coli, J. Struct. Biol. 129
(2000) 96–99.
[36] D.T. Gallagher, M. Mayhew, M.J. Holden, A. Howard, K.J. Kim, V.L. Vilker, The crystal
structure of chorismate lyase shows a new fold and a tightly retained product,
Proteins 44 (2001) 304–311.
[37] N. Smith, A.E. Roitberg, E. Rivera, A. Howard, M.J. Holden, M. Mayhew, S. Kaistha,
D.T. Gallagher, Structural analysis of ligand binding and catalysis in chorismate
lyase, Arch. Biochem. Biophys. 445 (2006) 72–80.
[38] J. Kopec, R. Schnell, G. Schneider, Structure of PA4019, a putative aromatic acid
decarboxylase from Pseudomonas aeruginosa, Acta Crystallogr. Sect. F: Struct. Biol.
Cryst. Commun. 67 (2011) 1184–1188.
[39] E.S. Rangarajan, Y. Li, P. Iannuzzi, A. Tocilj, L.W. Hung, A. Matte, M. Cygler, Crystal
structure of a dodecameric FMN-dependent UbiX-like decarboxylase (Pad1) from
Escherichia coli O157: H7, Protein Sci. 13 (2004) 3006–3016.
[40] A. Jacewicz, A. Izumi, K. Brunner, R. Schnell, G. Schneider, Structural insights into the
UbiD protein family from the crystal structure of PA0254 from Pseudomonas
aeruginosa, PLoS One 8 (2013) e63161.
[41] H.A. Schreuder, P.A. Prick, R.K. Wierenga, G. Vriend, K.S. Wilson, W.G. Hol, J. Drenth,
Crystal structure of the p-hydroxybenzoate hydroxylase-substrate complex reﬁned
at 1.9 A resolution. Analysis of the enzyme-substrate and enzyme-product complexes,
J. Mol. Biol. 208 (1989) 679–696.
[42] A.S. Lynch, E.C. Lin, Escherichia coli and Salmonella: cellular and molecular biology,
in: F.C. Neidhardt, R. Curtis III, J.L. Ingraham, E.C.C. Lin, K.B. Low, B. Magasanik,
W.S. Reznikoff, M. Riley, M. Schaechter, H.E. Umbarger (Eds.), Am. Soc. Microbiol.,
1996, pp. 1526–1538, (Washington, DC).
[43] D. Georgellis, O. Kwon, E.C. Lin, Quinones as the redox signal for the arc
two-component system of bacteria, Science 292 (2001) 2314–2316.
[44] R. Malpica, B. Franco, C. Rodriguez, O. Kwon, D. Georgellis, Identiﬁcation of a
quinone-sensitive redox switch in the ArcB sensor kinase, Proc. Nat. Acad. Sci. U.
S. A. 101 (2004) 13318–13323.
[45] M. Bekker, S. Alexeeva, W. Laan, G. Sawers, J. Teixeira de Mattos, K. Hellingwerf, The
ArcBA two-component system of Escherichia coli is regulated by the redox state of
both the ubiquinone and the menaquinone pool, J. Bacteriol. 192 (2010) 746–754.
[46] P. Sharma, S. Stagge, M. Bekker, K. Bettenbrock, K.J. Hellingwerf, Kinase activity of
ArcB from Escherichia coli is subject to regulation by both ubiquinone and
demethylmenaquinone, PLoS One 8 (2013) e75412.
[47] T.H. Bird, S. Du, C.E. Bauer, Autophosphorylation, phosphotransfer, and DNA-binding
properties of the RegB/RegA two-component regulatory system in Rhodobacter
capsulatus, J. Biol. Chem. 274 (1999) 16343–16348.
[48] S. Elsen, L.R. Swem, D.L. Swem, C.E. Bauer, RegB/RegA, a highly conserved
redox-responding global two-component regulatory system, Microbiol. Mol. Biol.
Rev. 68 (2004) 263–279.
[49] J. Wu, C.E. Bauer, RegB kinase activity is controlled in part by monitoring the ratio of
oxidized to reduced ubiquinones in the ubiquinone pool, MBio 1 (2010) e00272-10.
[50] L. Ernster, G. Dallner, Biochemical, physiological and medical aspects of ubiquinone
function, Biochim. Biophys. Acta 1271 (1995) 195–204.
[51] P. Forsmark-Andree, G. Dallner, L. Ernster, Endogenous ubiquinol prevents protein
modiﬁcation accompanying lipid peroxidation in beef heart submitochondrial particles,
Free Radic. Biol. Med. 19 (1995) 749–757.
[52] S. Padilla, T. Jonassen, M.A. Jiménez-Hidalgo, D.J. Fernández-Ayala, G. López-Lluch, B.
Marbois, P. Navas, C.F. Clarke, C. Santos-Ocaña, Demethoxy-Q, an intermediate of
1011L. Aussel et al. / Biochimica et Biophysica Acta 1837 (2014) 1004–1011coenzyme Q biosynthesis, fails to support respiration in Saccharomyces cerevisiae
and lacks antioxidant activity, J. Biol. Chem. 279 (2004) 25995–26004.
[53] B. Søballe, R.K. Poole, Ubiquinone limits oxidative stress in Escherichia coli,Microbiology
146 (2000) 787–796.
[54] B. Søballe, R.K. Poole, Requirement for ubiquinone downstream of cytochrome(s) b
in the oxygen-terminated respiratory chains of Escherichia coli K-12 revealed using a
null mutant allele of ubiCA, Microbiology 144 (1998) 361–373.
[55] U. Wissenbach, D. Ternes, G. Unden, An Escherichia coli mutant containing only
demethylmenaquinone, but nomenaquinone: effects on fumarate, dimethylsulfoxide,
trimethylamine N-oxide and nitrate respiration, Arch. Microbiol. 158 (1992) 68–73.
[56] T.H. Brondijk, D. Fiegen, D.J. Richardson, J.A. Cole, Roles of NapF, NapG and NapH,
subunits of the Escherichia coli periplasmic nitrate reductase, in ubiquinol oxidation,
Mol. Microbiol. 44 (2002) 245–255.
[57] T. Friedrich, K. Steinmüller, H. Weiss, The proton-pumping respiratory complex I of
bacteria and mitochondria and its homologue in chloroplasts, FEBS Lett. 367 (1995)
107–111.
[58] H.W. Taber, J.P. Mueller, P.F. Miller, A.S. Arrow, Bacterial uptake of aminoglycoside
antibiotics, Microbiol. Rev. 51 (1987) 439–457.
[59] B.D. Davis, L.L. Chen, P.C. Tai, Misread protein createsmembrane channels: an essential
step in the bactericidal action of aminoglycosides, Proc. Nat. Acad. Sci. U. S. A. 83 (1986)
6164–6168.
[60] B. Ezraty, A. Vergnes, M. Banzhaf, Y. Duverger, A. Huguenot, A.R. Brochado, S.Y. Su, L.
Espinosa, L. Loiseau, B. Py, A. Typas, F. Barras, Fe–S cluster biosynthesis controls uptake
of aminoglycosides in a ROS-less death pathway, Science 340 (2013) 1583–1587.
[61] H.W. Taber, E.A. Dellers, L.R. Lombardo, Menaquinone biosynthesis in Bacillus
subtilis: isolation of men mutants and evidence for clustering of men genes, J.
Bacteriol. 145 (1981) 321–327.
[62] M.R. Paradise, G. Cook, R.K. Poole, P.N. Rather, Mutations in aarE, the ubiA homolog
of Providencia stuartii, result in high-level aminoglycoside resistance and reduced
expression of the chromosomal aminoglycoside 2′-N-acetyltransferase, Antimicrob.
Agents Chemother. 42 (1998) 959–962.
[63] C.M. Collis, G.W. Grigg, An Escherichia coli mutant resistant to phleomycin,
bleomycin, and heat inactivation is defective in ubiquinone synthesis, J. Bacteriol.
171 (1989) 4792–4798.
[64] L.E. Bryan, H.M. Van Den Elzen, Effects of membrane-energy mutations and cations
on streptomycin and gentamicin accumulation by bacteria: a model for entry ofstreptomycin and gentamicin in susceptible and resistant bacteria, Antimicrob.
Agents Chemother. 12 (1977) 163–177.
[65] E.V. Stabb, J. Handelsman, Genetic analysis of zwittermicinA resistance in Escherichia
coli: effects onmembrane potential and RNA polymerase, Mol. Microbiol. 27 (1998)
311–322.
[66] F. Gomez, G.C.Monsalve, V. Tse, R. Saiki, E. Weng, L. Lee, C. Srinivasan, A.R. Frand, C.F.
Clarke, Delayed accumulation of intestinal coliform bacteria enhances life span and
stress resistance in Caenorhabditis elegans fed respiratory deﬁcient E. coli, BMC
Microbiol. 12 (2012) 300.
[67] B. Marteyn, N.P. West, D.F. Browning, J.A. Cole, J.G. Shaw, F. Palm, J. Mounier, M.C.
Prévost, P. Sansonetti, C.M. Tang, Modulation of Shigella virulence in response to
available oxygen in vivo, Nature 465 (2010) 355–358.
[68] J. Bar-Tana, B.J. Howlett, R. Hertz, Ubiquinone synthetic pathway in ﬂagellation of
Salmonella typhimurium, J. Bacteriol. 143 (1980) 637–643.
[69] L.A. Wessjohann, B. Sonntag, Prenylation of benzoic acid derivatives catalyzed by
a transferase from Escherichia coli overproduction: method development and
substrate speciﬁcity, Angew. Chem. Int. Ed. Engl. 35 (1996) 1697–1699.
[70] H.E. Knoell, Isolation of a soluble enzyme complex comprising the ubiquinone-8
synthesis apparatus from the cytoplasmic membrane of Escherichia coli, Biochem.
Biophys. Res. Commun. 91 (1979) 919–925.
[71] P. Gin, C.F. Clarke, Genetic evidence for a multi-subunit complex in coenzyme Q
biosynthesis in yeast and the role of the Coq1 hexaprenyl diphosphate synthase, J.
Biol. Chem. 280 (2005) 2676–2681.
[72] C.H. He, L.X. Xie, C.M. Allan, U.C. Tran, C.F. Clarke, Coenzyme Q supplementation or
over-expression of the yeast Coq8 putative kinase stabilizes multi-subunit Coq
polypeptide complexes in yeast coq null mutants, Biochim. Biophys. Acta (2013),
http://dx.doi.org/10.1016/j.bbalip.2013.12.017.
[73] M. Siebert, K. Severin, L. Heide, Formation of 4-hydroxybenzoate in Escherichia coli:
characterization of the ubiC gene and its encoded enzyme chorismate pyruvate-lyase,
Microbiology 140 (1994) 897–904.
[74] P. Stroobant, I.G. Young, F. Gibson, Mutants of Escherichia coli K-12 blocked in the
ﬁnal reaction of ubiquinone biosynthesis: characterization and genetic analysis, J.
Bacteriol. 109 (1972) 134–139.
[75] I.G. Young, P. Stroobant, C.G. Macdonald, F. Gibson, Pathway for ubiquinone biosyn-
thesis in Escherichia coli K-12: gene-enzyme relationships and intermediates, J.
Bacteriol. 114 (1973) 42–52.
